{
  "prompt_id": "stage_c_03",
  "stage": "C",
  "generated_at": "2025-10-21T18:25:42.287268Z",
  "metrics": {
    "tool_routing": {
      "score": 0.0,
      "details": {
        "expected": [
          "research_guidelines"
        ],
        "observed": [
          "web_search"
        ],
        "missing": [
          "research_guidelines"
        ],
        "extra": [
          "web_search"
        ]
      }
    },
    "citation_presence": {
      "score": 1.0
    },
    "citation_validity": {
      "score": 1.0,
      "details": {
        "total_count": 18,
        "scholarly_count": 6,
        "guideline_count": 0,
        "portal_count": 0,
        "other_count": 12,
        "malformed_count": 0,
        "domain_config_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367"
      },
      "citations": [
        {
          "id": "P1",
          "title": "Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review",
          "url": "https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-025-02463-y",
          "domain": "bmcmedresmethodol.biomedcentral.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "P2",
          "title": "A machine learning approach for multimodal data fusion for survival prediction in cancer patients",
          "url": "https://www.nature.com/articles/s41698-025-00917-6",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P4",
          "title": "Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine",
          "url": "https://www.nature.com/articles/s41571-025-01067-1",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P5",
          "title": "Biology-guided deep learning predicts prognosis and cancer immunotherapy response",
          "url": "https://www.nature.com/articles/s41467-023-40890-x.pdf",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P7",
          "title": "Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer",
          "url": "https://www.nature.com/articles/s41467-025-55847-5",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P8",
          "title": "Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data",
          "url": "https://www.nature.com/articles/s41591-024-03398-5",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "1",
          "title": "TRIPOD+AI statement: updated guidance for reporting clinical prediction models using AI/ML",
          "url": "https://www.bmj.com/content/385/bmj-2023-078378",
          "domain": "bmj.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "2",
          "title": "PROBAST-AI: updated risk of bias and applicability tool for AI-driven prediction models",
          "url": "https://www.bmj.com/content/388/bmj-2024-082505",
          "domain": "bmj.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "3",
          "title": "PROBAST: a tool to assess risk of bias and applicability of prediction model studies",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30596875/",
          "domain": "pubmed.ncbi.nlm.nih.gov",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "4",
          "title": "CONSORT-AI Extension",
          "url": "https://www.equator-network.org/reporting-guidelines/consort-artificial-intelligence/",
          "domain": "equator-network.org",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "5",
          "title": "SPIRIT-AI: guidelines for clinical trial protocols for interventions involving AI",
          "url": "https://www.nature.com/articles/s41591-020-1037-7",
          "domain": "nature.com",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "6",
          "title": "Vickers AJ, Elkin EB. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models",
          "url": "https://journals.sagepub.com/doi/10.1177/0272989X06295361",
          "domain": "journals.sagepub.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "7",
          "title": "A simple, step-by-step guide to interpreting decision curve analysis",
          "url": "https://diagnprognres.biomedcentral.com/articles/10.1186/s41512-019-0064-7",
          "domain": "diagnprognres.biomedcentral.com",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "8",
          "title": "The Cancer Imaging Archive (TCIA)",
          "url": "https://www.cancerimagingarchive.net/",
          "domain": "cancerimagingarchive.net",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "9",
          "title": "The Cancer Genome Atlas (TCGA)",
          "url": "https://www.cancer.gov/ccg/research/genome-sequencing/tcga",
          "domain": "cancer.gov",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "10",
          "title": "CPTAC collections (WSI/radiology)",
          "url": "https://www.cancerimagingarchive.net/collection/cptac-cm/",
          "domain": "cancerimagingarchive.net",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "11",
          "title": "METABRIC dataset (Synapse)",
          "url": "https://www.synapse.org/Synapse:syn1688369",
          "domain": "synapse.org",
          "kind": "other",
          "malformed": false
        },
        {
          "id": "12",
          "title": "IMvigor210 Data Access (EGA DAC)",
          "url": "https://ega-archive.org/dacs/EGAC00001001611",
          "domain": "ega-archive.org",
          "kind": "other",
          "malformed": false
        }
      ],
      "legacy_quality_score": 63.333333333333336,
      "legacy_validator": {
        "valid": false,
        "valid_count": 0,
        "total_count": 18,
        "issues": [
          "Citation 1: No authors specified",
          "Citation 1: Invalid or missing year",
          "Citation 1: No venue specified",
          "Citation 1: No meaningful snippet",
          "Citation 2: No authors specified",
          "Citation 2: Invalid or missing year",
          "Citation 2: No venue specified",
          "Citation 2: No DOI available",
          "Citation 2: No meaningful snippet",
          "Citation 3: No authors specified",
          "Citation 3: Invalid or missing year",
          "Citation 3: No venue specified",
          "Citation 3: No DOI available",
          "Citation 3: No meaningful snippet",
          "Citation 4: No authors specified",
          "Citation 4: Invalid or missing year",
          "Citation 4: No venue specified",
          "Citation 4: No DOI available",
          "Citation 4: No meaningful snippet",
          "Citation 5: No authors specified",
          "Citation 5: Invalid or missing year",
          "Citation 5: No venue specified",
          "Citation 5: No DOI available",
          "Citation 5: No meaningful snippet",
          "Citation 6: No authors specified",
          "Citation 6: Invalid or missing year",
          "Citation 6: No venue specified",
          "Citation 6: No DOI available",
          "Citation 6: No meaningful snippet",
          "Citation 7: No authors specified",
          "Citation 7: Invalid or missing year",
          "Citation 7: No venue specified",
          "Citation 7: No DOI available",
          "Citation 7: No meaningful snippet",
          "Citation 8: No authors specified",
          "Citation 8: Invalid or missing year",
          "Citation 8: No venue specified",
          "Citation 8: No DOI available",
          "Citation 8: No meaningful snippet",
          "Citation 9: No authors specified",
          "Citation 9: Invalid or missing year",
          "Citation 9: No venue specified",
          "Citation 9: No DOI available",
          "Citation 9: No meaningful snippet",
          "Citation 10: No authors specified",
          "Citation 10: Invalid or missing year",
          "Citation 10: No venue specified",
          "Citation 10: No DOI available",
          "Citation 10: No meaningful snippet",
          "Citation 11: No authors specified",
          "Citation 11: Invalid or missing year",
          "Citation 11: No venue specified",
          "Citation 11: No DOI available",
          "Citation 11: No meaningful snippet",
          "Citation 12: No authors specified",
          "Citation 12: Invalid or missing year",
          "Citation 12: No venue specified",
          "Citation 12: No meaningful snippet",
          "Citation 13: No authors specified",
          "Citation 13: Invalid or missing year",
          "Citation 13: No venue specified",
          "Citation 13: No meaningful snippet",
          "Citation 14: No authors specified",
          "Citation 14: Invalid or missing year",
          "Citation 14: No venue specified",
          "Citation 14: No DOI available",
          "Citation 14: No meaningful snippet",
          "Citation 15: No authors specified",
          "Citation 15: Invalid or missing year",
          "Citation 15: No venue specified",
          "Citation 15: No DOI available",
          "Citation 15: No meaningful snippet",
          "Citation 16: No authors specified",
          "Citation 16: Invalid or missing year",
          "Citation 16: No venue specified",
          "Citation 16: No DOI available",
          "Citation 16: No meaningful snippet",
          "Citation 17: No authors specified",
          "Citation 17: Invalid or missing year",
          "Citation 17: No venue specified",
          "Citation 17: No DOI available",
          "Citation 17: No meaningful snippet",
          "Citation 18: No authors specified",
          "Citation 18: Invalid or missing year",
          "Citation 18: No venue specified",
          "Citation 18: No DOI available",
          "Citation 18: No meaningful snippet"
        ],
        "individual_results": [
          {
            "valid": false,
            "score": 65.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No meaningful snippet"
            ],
            "completeness": 42.857142857142854
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 65.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No meaningful snippet"
            ],
            "completeness": 42.857142857142854
          },
          {
            "valid": false,
            "score": 65.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No meaningful snippet"
            ],
            "completeness": 42.857142857142854
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          }
        ]
      }
    },
    "fallback_robustness": {
      "score": 0.0
    },
    "asks_questions": {
      "score": 0.0
    },
    "rag_fidelity": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The agent provides a comprehensive and actionable plan to address the user's ambitious goal of curing cancer with AI. It correctly identifies the infeasibility of the user's timeline and reframes the objective to a more realistic and clinically relevant goal: building and externally validating a calibrated, decision-usable predictor of immunotherapy benefit. The plan is well-structured, detailing problem framing, specific experiments with hypotheses, setups, baselines, and metrics, and a realistic 6-month timeline with milestones. Crucially, the plan emphasizes rigorous validation, clinical utility assessment (using decision curve analysis), and transparent reporting, aligning with best practices and cited evidence such as TRIPOD-AI and PROBAST-AI. The agent explicitly cites relevant research papers ([P1], [P2], [P4], [P5], [P7], [P8]) and reporting guidelines ([1], [2], [4], [5], [6], [7]) throughout the plan, demonstrating strong grounding in the provided evidence. The plan is detailed, logical, and directly addresses the user's underlying interest in AI for cancer treatment, while managing expectations about the timeline and scope.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent provides a comprehensive and actionable plan to address the user's ambitious goal of curing cancer with AI. It correctly identifies the infeasibility of the user's timeline and reframes the objective to a more realistic and clinically relevant goal: building and externally validating a calibrated, decision-usable predictor of immunotherapy benefit. The plan is well-structured, detailing problem framing, specific experiments with hypotheses, setups, baselines, and metrics, and a realistic 6-month timeline with milestones. Crucially, the plan emphasizes rigorous validation, clinical utility assessment (using decision curve analysis), and transparent reporting, aligning with best practices and cited evidence such as TRIPOD-AI and PROBAST-AI. The agent explicitly cites relevant research papers ([P1], [P2], [P4], [P5], [P7], [P8]) and reporting guidelines ([1], [2], [4], [5], [6], [7]) throughout the plan, demonstrating strong grounding in the provided evidence. The plan is detailed, logical, and directly addresses the user's underlying interest in AI for cancer treatment, while managing expectations about the timeline and scope.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response synthesizes cited evidence accurately with clear attribution and no contradictions. It directly references multiple sources (e.g., [P1], [P2], [P8]) to support claims about external validation, multimodal data fusion, and clinical utility, aligning with the evidence summary and extracted citations. The plan is grounded in specific findings from the literature, such as the feasibility of using routine clinical data for immunotherapy prediction [P8] and the importance of reporting standards [1][2], without introducing unsupported or contradictory information.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response synthesizes cited evidence accurately with clear attribution and no contradictions. It directly references multiple sources (e.g., [P1], [P2], [P8]) to support claims about external validation, multimodal data fusion, and clinical utility, aligning with the evidence summary and extracted citations. The plan is grounded in specific findings from the literature, such as the feasibility of using routine clinical data for immunotherapy prediction [P8] and the importance of reporting standards [1][2], without introducing unsupported or contradictory information.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response accurately synthesizes cited evidence from sources like [P1] (scoping review on validation gaps), [P2] (multimodal fusion benefits), [P8] (routine data for ICI prediction), and reporting guidelines ([1], [2], etc.), with clear inline attributions throughout experiments, objectives, and timeline. No contradictions, fabrications, or ignored citations; all claims are faithfully grounded in the provided evidence summaries and extracted sources without omissions impacting fidelity.\", \"confidence\": \"high\"}",
          "rationale": "The response accurately synthesizes cited evidence from sources like [P1] (scoping review on validation gaps), [P2] (multimodal fusion benefits), [P8] (routine data for ICI prediction), and reporting guidelines ([1], [2], etc.), with clear inline attributions throughout experiments, objectives, and timeline. No contradictions, fabrications, or ignored citations; all claims are faithfully grounded in the provided evidence summaries and extracted sources without omissions impacting fidelity.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "citation_relevance": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The citations directly support the claims made in the response. For example, [P1] is cited to support the infeasibility of curing cancer tomorrow and to prioritize gaps in external validation and clinical utility. [P8] and [P2] are cited to support the objective of building a predictor of immunotherapy benefit using clinical and multimodal data, respectively. The other citations similarly provide direct evidence or methodological guidance for the proposed plan.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The citations directly support the claims made in the response. For example, [P1] is cited to support the infeasibility of curing cancer tomorrow and to prioritize gaps in external validation and clinical utility. [P8] and [P2] are cited to support the objective of building a predictor of immunotherapy benefit using clinical and multimodal data, respectively. The other citations similarly provide direct evidence or methodological guidance for the proposed plan.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"All citations directly support specific claims and methodological choices in the response, such as using external validation (P1), multimodal fusion (P2), reporting standards (TRIPOD-AI, PROBAST-AI), datasets (TCGA, CPTAC), and evaluation metrics (decision curve analysis). Each citation is relevant to the claims made about feasibility, model design, validation, and clinical translation.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "All citations directly support specific claims and methodological choices in the response, such as using external validation (P1), multimodal fusion (P2), reporting standards (TRIPOD-AI, PROBAST-AI), datasets (TCGA, CPTAC), and evaluation metrics (decision curve analysis). Each citation is relevant to the claims made about feasibility, model design, validation, and clinical translation.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"Citations directly support claims throughout the response; for example, [P1] backs the scoping review on external validation gaps in oncology ML, [P8] and [P2] support hypotheses on clinical data for immunotherapy prediction and multimodal fusion outperforming single-modality models, [1] and [2] directly reference TRIPOD+AI and PROBAST-AI for reporting and bias assessment, and data sources like [8]-[12] align with cohort recommendations. No irrelevant citations observed.\", \"confidence\": \"high\"}",
          "rationale": "Citations directly support claims throughout the response; for example, [P1] backs the scoping review on external validation gaps in oncology ML, [P8] and [P2] support hypotheses on clinical data for immunotherapy prediction and multimodal fusion outperforming single-modality models, [1] and [2] directly reference TRIPOD+AI and PROBAST-AI for reporting and bias assessment, and data sources like [8]-[12] align with cohort recommendations. No irrelevant citations observed.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "source_fit": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The agent provides a comprehensive and realistic plan for using AI to address cancer, acknowledging the infeasibility of the user's original goal. It breaks down the problem into manageable experiments, outlines clear objectives and success criteria, and suggests a detailed timeline. Crucially, it cites numerous relevant and recent scholarly articles ([P1]-[P8], [1]-[12]) that are appropriate for the user's stated goal and the complexity of the proposed plan. The sources cover key areas like external validation, multimodal data fusion, reporting guidelines (TRIPOD-AI, PROBAST-AI), and specific datasets, demonstrating a strong fit.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent provides a comprehensive and realistic plan for using AI to address cancer, acknowledging the infeasibility of the user's original goal. It breaks down the problem into manageable experiments, outlines clear objectives and success criteria, and suggests a detailed timeline. Crucially, it cites numerous relevant and recent scholarly articles ([P1]-[P8], [1]-[12]) that are appropriate for the user's stated goal and the complexity of the proposed plan. The sources cover key areas like external validation, multimodal data fusion, reporting guidelines (TRIPOD-AI, PROBAST-AI), and specific datasets, demonstrating a strong fit.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The sources cited are highly appropriate for the user's goal of developing an AI-based cancer treatment plan, with recent (2024-2025) publications from high-impact venues like Nature, BMJ, and BMC journals that directly address immunotherapy prediction, multimodal data fusion, clinical validation, and reporting standards - precisely matching the technical sophistication required for this ambitious but realistic research direction.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The sources cited are highly appropriate for the user's goal of developing an AI-based cancer treatment plan, with recent (2024-2025) publications from high-impact venues like Nature, BMJ, and BMC journals that directly address immunotherapy prediction, multimodal data fusion, clinical validation, and reporting standards - precisely matching the technical sophistication required for this ambitious but realistic research direction.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The sources cited in the agent response are highly appropriate for the user's ambitious goal of using AI in cancer research, reframed realistically to focus on predictive modeling and validation. All sources are recent (primarily 2023-2025 publications) and from prestigious, peer-reviewed venues such as Nature, BMJ, and BMC, covering key topics like ML for immunotherapy prediction, multimodal data fusion, external validation, and reporting guidelines (e.g., TRIPOD+AI, PROBAST-AI). They match the expertise level implied by the prompt (enthusiastic but non-expert) by grounding the plan in evidence-based, accessible methodologies without overwhelming detail, while data sources like TCGA and CPTAC are standard and feasible for implementation.\", \"confidence\": \"high\"}",
          "rationale": "The sources cited in the agent response are highly appropriate for the user's ambitious goal of using AI in cancer research, reframed realistically to focus on predictive modeling and validation. All sources are recent (primarily 2023-2025 publications) and from prestigious, peer-reviewed venues such as Nature, BMJ, and BMC, covering key topics like ML for immunotherapy prediction, multimodal data fusion, external validation, and reporting guidelines (e.g., TRIPOD+AI, PROBAST-AI). They match the expertise level implied by the prompt (enthusiastic but non-expert) by grounding the plan in evidence-based, accessible methodologies without overwhelming detail, while data sources like TCGA and CPTAC are standard and feasible for implementation.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "citation_quality": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The response provides a detailed, multi-stage plan for using AI to address cancer treatment, acknowledging the infeasibility of an immediate cure and focusing on achievable goals within a realistic timeframe. It cites numerous scholarly articles and established guidelines (e.g., TRIPOD-AI, PROBAST-AI, CONSORT-AI, SPIRIT-AI, TCGA, CPTAC) that directly support the proposed methodologies, experimental designs, and reporting standards. The citations are real, well-formatted, and directly relevant to the claims made about the plan's scientific rigor and clinical applicability.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response provides a detailed, multi-stage plan for using AI to address cancer treatment, acknowledging the infeasibility of an immediate cure and focusing on achievable goals within a realistic timeframe. It cites numerous scholarly articles and established guidelines (e.g., TRIPOD-AI, PROBAST-AI, CONSORT-AI, SPIRIT-AI, TCGA, CPTAC) that directly support the proposed methodologies, experimental designs, and reporting standards. The citations are real, well-formatted, and directly relevant to the claims made about the plan's scientific rigor and clinical applicability.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"All citations are real, well-formatted, and directly support claims, with sources from authoritative scholarly journals (e.g., Nature, BMJ, BMC) and guidelines/portals (e.g., TCGA, TCIA), aligning with the 2.0 rubric criteria for citation quality.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "All citations are real, well-formatted, and directly support claims, with sources from authoritative scholarly journals (e.g., Nature, BMJ, BMC) and guidelines/portals (e.g., TCGA, TCIA), aligning with the 2.0 rubric criteria for citation quality.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"All citations are real, from peer-reviewed scholarly journals (e.g., Nature, BMJ, BMC) or authoritative portals (e.g., Cancer.gov, TCIA), well-formatted with titles and direct URLs, and directly support claims such as external validation gaps [P1], multimodal fusion benefits [P2], reporting guidelines [1][2], and data sources [8-12]. No fabricated, irrelevant, or less authoritative sources present.\", \"confidence\": \"high\"}",
          "rationale": "All citations are real, from peer-reviewed scholarly journals (e.g., Nature, BMJ, BMC) or authoritative portals (e.g., Cancer.gov, TCIA), well-formatted with titles and direct URLs, and directly support claims such as external validation gaps [P1], multimodal fusion benefits [P2], reporting guidelines [1][2], and data sources [8-12]. No fabricated, irrelevant, or less authoritative sources present.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "question_quality": {
      "score": 1.3333333333333333,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent's response is excellent. It directly addresses the user's ambitious goal by first providing a reality check and then proposing a feasible, phased plan. The plan is detailed, well-structured, and grounded in current research and best practices, as evidenced by the numerous citations to relevant papers and guidelines (e.g., TRIPOD-AI, PROBAST-AI, CONSORT-AI, SPIRIT-AI). The agent breaks down the problem into specific experiments with clear hypotheses, setups, baselines, and metrics. The timeline is realistic for the proposed scope. The agent also proactively asks a clarifying question to tailor the plan further, demonstrating a deep understanding of the user's request and the domain.\", \"confidence\": \"high\"}",
          "rationale": "The agent's response is excellent. It directly addresses the user's ambitious goal by first providing a reality check and then proposing a feasible, phased plan. The plan is detailed, well-structured, and grounded in current research and best practices, as evidenced by the numerous citations to relevant papers and guidelines (e.g., TRIPOD-AI, PROBAST-AI, CONSORT-AI, SPIRIT-AI). The agent breaks down the problem into specific experiments with clear hypotheses, setups, baselines, and metrics. The timeline is realistic for the proposed scope. The agent also proactively asks a clarifying question to tailor the plan further, demonstrating a deep understanding of the user's request and the domain.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 0.0,\n  \"rationale\": \"The agent response does not ask any clarifying questions, instead providing a detailed plan without addressing the user's unrealistic timeline or seeking context about their resources, expertise, or constraints, which violates the rubric's requirement for targeted clarifying questions grounded in context.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The agent response does not ask any clarifying questions, instead providing a detailed plan without addressing the user's unrealistic timeline or seeking context about their resources, expertise, or constraints, which violates the rubric's requirement for targeted clarifying questions grounded in context.",
          "confidence": "high",
          "score": 0.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent's response includes a single, highly targeted clarifying question in the 'Optional next step' section, asking for specifics on tumor type and data access (routine labs vs. multimodal), which is directly grounded in the context of the proposed 6-month plan, experiments, and data requirements (e.g., TCGA/CPTAC cohorts). This enables customization of milestones, datasets, and analysis plans per TRIPOD-AI guidelines, aligning perfectly with rubric criteria for 2.0. No generic or counterproductive questions present.\", \"confidence\": \"high\"}",
          "rationale": "The agent's response includes a single, highly targeted clarifying question in the 'Optional next step' section, asking for specifics on tumor type and data access (routine labs vs. multimodal), which is directly grounded in the context of the proposed 6-month plan, experiments, and data requirements (e.g., TCGA/CPTAC cohorts). This enables customization of milestones, datasets, and analysis plans per TRIPOD-AI guidelines, aligning perfectly with rubric criteria for 2.0. No generic or counterproductive questions present.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "actionability": {
      "score": 0.9,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 0.8,\n  \"rationale\": \"The response provides a detailed, multi-stage plan with specific experiments, hypotheses, data sources, models, and metrics. It includes a clear timeline with milestones. However, it lacks concrete executable commands or parameters for the AI models themselves, which would elevate it to a 1.0. The plan is highly actionable, but the user would need to fill in the specifics of implementing the ML models and data processing pipelines.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The response provides a detailed, multi-stage plan with specific experiments, hypotheses, data sources, models, and metrics. It includes a clear timeline with milestones. However, it lacks concrete executable commands or parameters for the AI models themselves, which would elevate it to a 1.0. The plan is highly actionable, but the user would need to fill in the specifics of implementing the ML models and data processing pipelines.",
          "confidence": "high",
          "score": 0.8
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1.0,\n  \"rationale\": \"The response provides concrete executable steps including specific data sources (TCGA, CPTAC, TCIA, METABRIC), model architectures (XGBoost, tab-transformer, DeepSurv), validation procedures (nested CV, external validation), metrics (AUROC, C-index, Brier score), and a detailed 6-month timeline with monthly milestones. It includes commands, parameters, and expected outcomes as required for the highest rubric score.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response provides concrete executable steps including specific data sources (TCGA, CPTAC, TCIA, METABRIC), model architectures (XGBoost, tab-transformer, DeepSurv), validation procedures (nested CV, external validation), metrics (AUROC, C-index, Brier score), and a detailed 6-month timeline with monthly milestones. It includes commands, parameters, and expected outcomes as required for the highest rubric score.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 0.9, \"rationale\": \"The response delivers a highly structured 6-month plan with concrete executable steps across problem framing, five detailed experiments (including hypotheses, data sources with links, specific features, models like XGBoost and tab-transformer, validation strategies, baselines, metrics such as AUROC and C-index, and expected outcomes), a monthly timeline with milestones (e.g., secure IRB, implement preprocessing, train baselines), and reporting guidelines. It meets criteria for parameters and outcomes but falls short of 1.0 due to absence of literal code commands or scripts, requiring minor user implementation gaps like data access specifics.\", \"confidence\": \"high\"}",
          "rationale": "The response delivers a highly structured 6-month plan with concrete executable steps across problem framing, five detailed experiments (including hypotheses, data sources with links, specific features, models like XGBoost and tab-transformer, validation strategies, baselines, metrics such as AUROC and C-index, and expected outcomes), a monthly timeline with milestones (e.g., secure IRB, implement preprocessing, train baselines), and reporting guidelines. It meets criteria for parameters and outcomes but falls short of 1.0 due to absence of literal code commands or scripts, requiring minor user implementation gaps like data access specifics.",
          "confidence": "high",
          "score": 0.9
        }
      ]
    },
    "persona_compliance": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent adopts a highly encouraging and guiding tone throughout the response. It begins by acknowledging the user's ambitious goal and then provides a structured, realistic, and actionable plan. The agent uses phrases like \\\"Reality check: 'Cure cancer with AI tomorrow' is infeasible\\\" to gently guide the user towards a more achievable objective, and then proceeds to outline a \\\"6-month, publication-grade plan\\\" with clear objectives, experiments, and a timeline. The response is rich with details, references, and even offers further assistance based on the user's input, all of which contribute to a consistently supportive and mentor-like persona.\", \"confidence\": \"high\"}",
          "rationale": "The agent adopts a highly encouraging and guiding tone throughout the response. It begins by acknowledging the user's ambitious goal and then provides a structured, realistic, and actionable plan. The agent uses phrases like \"Reality check: 'Cure cancer with AI tomorrow' is infeasible\" to gently guide the user towards a more achievable objective, and then proceeds to outline a \"6-month, publication-grade plan\" with clear objectives, experiments, and a timeline. The response is rich with details, references, and even offers further assistance based on the user's input, all of which contribute to a consistently supportive and mentor-like persona.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response consistently adopts an encouraging and guiding mentor persona by first providing a reality check on the user's ambitious goal ('Cure cancer with AI tomorrow' is infeasible), then constructively reframing it into a feasible 6-month plan with clear objectives, experiments, and milestones. It offers detailed, actionable steps, cites relevant evidence, and maintains a supportive tone throughout, aligning with the rubric's criteria for a consistently encouraging and guiding mentor persona.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response consistently adopts an encouraging and guiding mentor persona by first providing a reality check on the user's ambitious goal ('Cure cancer with AI tomorrow' is infeasible), then constructively reframing it into a feasible 6-month plan with clear objectives, experiments, and milestones. It offers detailed, actionable steps, cites relevant evidence, and maintains a supportive tone throughout, aligning with the rubric's criteria for a consistently encouraging and guiding mentor persona.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response embodies a consistently encouraging and guiding mentor persona by acknowledging the user's ambitious goal with a constructive reality check, then providing a detailed, structured 6-month plan with clear objectives, experiments, timelines, success criteria, and evidence-based citations. It guides the user through feasible steps toward meaningful AI applications in oncology, emphasizes clinical utility and rigor, and ends with an invitation for further personalization, fostering motivation without dismissal.\", \"confidence\": \"high\"}",
          "rationale": "The response embodies a consistently encouraging and guiding mentor persona by acknowledging the user's ambitious goal with a constructive reality check, then providing a detailed, structured 6-month plan with clear objectives, experiments, timelines, success criteria, and evidence-based citations. It guides the user through feasible steps toward meaningful AI applications in oncology, emphasizes clinical utility and rigor, and ends with an invitation for further personalization, fostering motivation without dismissal.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "stage_awareness": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The user's prompt is highly ambitious and unrealistic ('cure cancer with AI tomorrow'). The agent immediately addresses this by providing a 'reality check' and reframing the goal into a feasible 6-month plan. This demonstrates a clear understanding of the user's initial, albeit unrealistic, stage and a skillful redirection towards a more achievable research objective. The plan is detailed, structured, and tailored to the research context of AI in cancer treatment, including specific experiments, success criteria, and a timeline. This aligns perfectly with the criteria for a score of 2.0.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The user's prompt is highly ambitious and unrealistic ('cure cancer with AI tomorrow'). The agent immediately addresses this by providing a 'reality check' and reframing the goal into a feasible 6-month plan. This demonstrates a clear understanding of the user's initial, albeit unrealistic, stage and a skillful redirection towards a more achievable research objective. The plan is detailed, structured, and tailored to the research context of AI in cancer treatment, including specific experiments, success criteria, and a timeline. This aligns perfectly with the criteria for a score of 2.0.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response clearly recognizes the user's unrealistic timeline ('cure cancer with AI tomorrow') and explicitly reframes it as infeasible, then tailors guidance to a realistic 6-month research plan focused on achievable, clinically meaningful objectives like building and validating predictors of immunotherapy benefit, aligning with the user's implied research stage (stage C) and constraint of an impossible timeline.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response clearly recognizes the user's unrealistic timeline ('cure cancer with AI tomorrow') and explicitly reframes it as infeasible, then tailors guidance to a realistic 6-month research plan focused on achievable, clinically meaningful objectives like building and validating predictors of immunotherapy benefit, aligning with the user's implied research stage (stage C) and constraint of an impossible timeline.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response clearly recognizes the user's early, overambitious research stage by providing an explicit reality check on the infeasibility of 'curing cancer with AI tomorrow' and reframes it into a realistic 6-month plan focused on achievable goals like model validation and clinical utility. Guidance is tailored with step-by-step experiments, timelines starting from basic data access and governance (Month 0-1), and progressive milestones that align with an ideation-stage user, avoiding jumps ahead while incorporating evidence-based standards (e.g., TRIPOD-AI). This matches rubric criteria for 2.0.\", \"confidence\": \"high\"}",
          "rationale": "The response clearly recognizes the user's early, overambitious research stage by providing an explicit reality check on the infeasibility of 'curing cancer with AI tomorrow' and reframes it into a realistic 6-month plan focused on achievable goals like model validation and clinical utility. Guidance is tailored with step-by-step experiments, timelines starting from basic data access and governance (Month 0-1), and progressive milestones that align with an ideation-stage user, avoiding jumps ahead while incorporating evidence-based standards (e.g., TRIPOD-AI). This matches rubric criteria for 2.0.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "tone_constructive": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response directly addresses the user's ambitious goal by providing a realistic, structured, and actionable plan. It acknowledges the infeasibility of the \\\"tomorrow\\\" timeline while offering a concrete, albeit challenging, 6-month roadmap. The tone is encouraging and supportive, framing the user's ambition within the bounds of scientific rigor and current research. The detailed breakdown of experiments, success criteria, and timeline demonstrates a commitment to guiding the user toward a meaningful outcome.\", \"confidence\": \"high\"}",
          "rationale": "The response directly addresses the user's ambitious goal by providing a realistic, structured, and actionable plan. It acknowledges the infeasibility of the \"tomorrow\" timeline while offering a concrete, albeit challenging, 6-month roadmap. The tone is encouraging and supportive, framing the user's ambition within the bounds of scientific rigor and current research. The detailed breakdown of experiments, success criteria, and timeline demonstrates a commitment to guiding the user toward a meaningful outcome.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 2.0,\n  \"rationale\": \"The response maintains a constructive and motivating tone throughout by acknowledging the user's ambitious goal while providing a realistic, evidence-based 6-month plan with specific objectives, experiments, and milestones. It encourages progress by focusing on achievable, clinically meaningful improvements in cancer treatment using AI, supported by recent research and guidelines, without being discouraging about the original timeline.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response maintains a constructive and motivating tone throughout by acknowledging the user's ambitious goal while providing a realistic, evidence-based 6-month plan with specific objectives, experiments, and milestones. It encourages progress by focusing on achievable, clinically meaningful improvements in cancer treatment using AI, supported by recent research and guidelines, without being discouraging about the original timeline.",
          "confidence": "high",
          "score": 2.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response employs a constructive and motivating tone by acknowledging the user's ambitious goal with a gentle reality check, then pivoting to a detailed, achievable 6-month plan with clear objectives, experiments, milestones, and evidence-based guidance, encouraging progress toward meaningful clinical impact without dismissing the user's enthusiasm (rubric: 2.0 for constructive, motivating tone).\", \"confidence\": \"high\"}",
          "rationale": "The response employs a constructive and motivating tone by acknowledging the user's ambitious goal with a gentle reality check, then pivoting to a detailed, achievable 6-month plan with clear objectives, experiments, milestones, and evidence-based guidance, encouraging progress toward meaningful clinical impact without dismissing the user's enthusiasm (rubric: 2.0 for constructive, motivating tone).",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "expectation_management": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 1, \"rationale\": \"The agent directly addresses the infeasibility of the user's request ('Cure cancer with AI tomorrow' is infeasible) and reframes it into a realistic, actionable 6-month plan. It sets clear, measurable objectives and outlines a structured approach with experiments and a timeline, demonstrating realistic expectation management.\", \"confidence\": \"high\"}",
          "rationale": "The agent directly addresses the infeasibility of the user's request ('Cure cancer with AI tomorrow' is infeasible) and reframes it into a realistic, actionable 6-month plan. It sets clear, measurable objectives and outlines a structured approach with experiments and a timeline, demonstrating realistic expectation management.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly reframes the user's infeasible goal of 'curing cancer with AI tomorrow' by stating it is 'infeasible' and instead proposes a realistic 6-month plan focused on measurable improvements in treatment selection and outcome prediction, aligning with the rubric's requirement to set realistic expectations or reframe infeasible goals.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly reframes the user's infeasible goal of 'curing cancer with AI tomorrow' by stating it is 'infeasible' and instead proposes a realistic 6-month plan focused on measurable improvements in treatment selection and outcome prediction, aligning with the rubric's requirement to set realistic expectations or reframe infeasible goals.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The response sets realistic expectations by explicitly stating that curing cancer with AI tomorrow is infeasible and reframes the goal into a structured 6-month plan for clinically meaningful improvements in treatment prediction and validation, supported by evidence and guidelines (e.g., TRIPOD-AI, PROBAST-AI). This aligns with the rubric criteria for reframing infeasible goals.\",\"confidence\":\"high\"}",
          "rationale": "The response sets realistic expectations by explicitly stating that curing cancer with AI tomorrow is infeasible and reframes the goal into a structured 6-month plan for clinically meaningful improvements in treatment prediction and validation, supported by evidence and guidelines (e.g., TRIPOD-AI, PROBAST-AI). This aligns with the rubric criteria for reframing infeasible goals.",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "plan_completeness": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response provides a comprehensive plan that includes hypotheses, methodology (experiments), evaluation metrics, necessary resources (data sources, tools), and a detailed timeline with milestones. All required components for a complete plan are present.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response provides a comprehensive plan that includes hypotheses, methodology (experiments), evaluation metrics, necessary resources (data sources, tools), and a detailed timeline with milestones. All required components for a complete plan are present.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response includes hypotheses (e.g., 'A rigorously validated ML model using routine labs and clinical variables will predict benefit from immune checkpoint inhibitors'), methodology (e.g., nested cross-validation, model specifications, data sources), evaluation (e.g., AUROC, calibration, decision-curve analysis), resources (e.g., TCGA, CPTAC datasets, computational tools), and milestones (e.g., timeline with specific monthly goals). All rubric elements are present.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response includes hypotheses (e.g., 'A rigorously validated ML model using routine labs and clinical variables will predict benefit from immune checkpoint inhibitors'), methodology (e.g., nested cross-validation, model specifications, data sources), evaluation (e.g., AUROC, calibration, decision-curve analysis), resources (e.g., TCGA, CPTAC datasets, computational tools), and milestones (e.g., timeline with specific monthly goals). All rubric elements are present.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The plan includes clear hypotheses for each of the five experiments (e.g., 'A rigorously validated ML model using routine labs and clinical variables will predict benefit from immune checkpoint inhibitors'), detailed methodology in setups (data, models, validation), evaluation via metrics (AUROC, C-index, DCA, calibration), resources (data sources like TCGA/CPTAC, models like XGBoost, guidelines like TRIPOD-AI), and milestones (monthly timeline with specific deliverables like baseline metrics and external validation reports), satisfying all rubric criteria.\",\"confidence\":\"high\"}",
          "rationale": "The plan includes clear hypotheses for each of the five experiments (e.g., 'A rigorously validated ML model using routine labs and clinical variables will predict benefit from immune checkpoint inhibitors'), detailed methodology in setups (data, models, validation), evaluation via metrics (AUROC, C-index, DCA, calibration), resources (data sources like TCGA/CPTAC, models like XGBoost, guidelines like TRIPOD-AI), and milestones (monthly timeline with specific deliverables like baseline metrics and external validation reports), satisfying all rubric criteria.",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "risk_mitigation": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 1, \"rationale\": \"The agent provides a detailed plan to cure cancer with AI, which includes multiple experiments, a timeline, and success criteria. Each experiment is paired with specific hypotheses, setups, baselines, metrics, and expected outcomes. The plan also incorporates risk mitigation strategies by acknowledging the infeasibility of the original request and proposing a more realistic, phased approach. It emphasizes external validation, clinical utility assessment (e.g., decision-curve analysis), and transparent reporting (TRIPOD-AI, PROBAST-AI), which are crucial for mitigating risks associated with AI model development and deployment in healthcare.\", \"confidence\": \"high\"}",
          "rationale": "The agent provides a detailed plan to cure cancer with AI, which includes multiple experiments, a timeline, and success criteria. Each experiment is paired with specific hypotheses, setups, baselines, metrics, and expected outcomes. The plan also incorporates risk mitigation strategies by acknowledging the infeasibility of the original request and proposing a more realistic, phased approach. It emphasizes external validation, clinical utility assessment (e.g., decision-curve analysis), and transparent reporting (TRIPOD-AI, PROBAST-AI), which are crucial for mitigating risks associated with AI model development and deployment in healthcare.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response explicitly pairs risks with mitigation strategies throughout the plan. For example, it addresses the risk of model overfitting and lack of generalizability by emphasizing external validation, calibration, and transportability assessment (Experiment 1, 3). It mitigates reporting and bias risks by adhering to TRIPOD-AI, PROBAST-AI, and RQS 2.0 guidelines (Experiment 5). It also includes strategies for data limitations (e.g., using public cohorts, temporal validation) and clinical translation risks (e.g., silent-mode evaluation protocols).\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response explicitly pairs risks with mitigation strategies throughout the plan. For example, it addresses the risk of model overfitting and lack of generalizability by emphasizing external validation, calibration, and transportability assessment (Experiment 1, 3). It mitigates reporting and bias risks by adhering to TRIPOD-AI, PROBAST-AI, and RQS 2.0 guidelines (Experiment 5). It also includes strategies for data limitations (e.g., using public cohorts, temporal validation) and clinical translation risks (e.g., silent-mode evaluation protocols).",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":1,\"rationale\":\"The agent response identifies multiple risks associated with AI in oncology (e.g., lack of external validation and clinical utility [P1], model degradation in external cohorts [P1], overfitting via data leakage, bias, poor calibration, and robustness issues like missingness or shifts) and pairs them explicitly with mitigation strategies (e.g., prioritizing external validation and transportability assessments, nested CV with leakage controls, recalibration and domain adaptation in Experiment 3, sensitivity/subgroup analyses, PROBAST-AI bias assessment, TRIPOD-AI reporting, and decision-curve analysis for utility [1][2][6][7]). This aligns with the rubric criterion for pairing risks with mitigations.\",\"confidence\":\"high\"}",
          "rationale": "The agent response identifies multiple risks associated with AI in oncology (e.g., lack of external validation and clinical utility [P1], model degradation in external cohorts [P1], overfitting via data leakage, bias, poor calibration, and robustness issues like missingness or shifts) and pairs them explicitly with mitigation strategies (e.g., prioritizing external validation and transportability assessments, nested CV with leakage controls, recalibration and domain adaptation in Experiment 3, sensitivity/subgroup analyses, PROBAST-AI bias assessment, TRIPOD-AI reporting, and decision-curve analysis for utility [1][2][6][7]). This aligns with the rubric criterion for pairing risks with mitigations.",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "feasibility_analysis": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 1, \"rationale\": \"The response provides a detailed plan that addresses feasibility across skills (experimental design, model development, validation, reporting), data (identifying specific datasets like TCGA, CPTAC, TCIA, METABRIC, IMvigor210, and outlining data types like routine labs, clinical variables, genomics, pathology, radiology), and compute (implied by the complexity of the models and data processing, though not explicitly detailed). The plan is structured into problem framing, experiments, and a timeline, demonstrating a comprehensive approach to feasibility.\", \"confidence\": \"high\"}",
          "rationale": "The response provides a detailed plan that addresses feasibility across skills (experimental design, model development, validation, reporting), data (identifying specific datasets like TCGA, CPTAC, TCIA, METABRIC, IMvigor210, and outlining data types like routine labs, clinical variables, genomics, pathology, radiology), and compute (implied by the complexity of the models and data processing, though not explicitly detailed). The plan is structured into problem framing, experiments, and a timeline, demonstrating a comprehensive approach to feasibility.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:deepseek/deepseek-v3.2-exp",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response evaluates feasibility across skills (e.g., model development, validation techniques), data (e.g., use of TCGA, CPTAC, TCIA datasets, data preprocessing, access considerations), and compute (e.g., model training, validation procedures, computational requirements implied by experiments), satisfying the rubric criteria for a score of 1.\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response evaluates feasibility across skills (e.g., model development, validation techniques), data (e.g., use of TCGA, CPTAC, TCIA datasets, data preprocessing, access considerations), and compute (e.g., model training, validation procedures, computational requirements implied by experiments), satisfying the rubric criteria for a score of 1.",
          "confidence": "high",
          "score": 1.0
        },
        {
          "judge": "openrouter:x-ai/grok-4-fast",
          "raw": "{\"score\":0,\"rationale\":\"The agent response provides a reality check on the infeasibility of curing cancer tomorrow and outlines a 6-month plan focusing on data sources (e.g., TCGA, CPTAC) and experiments, but it does not evaluate feasibility across skills (e.g., required ML expertise) or compute (e.g., hardware needs for multimodal models or WSI processing), as required by the rubric.\",\"confidence\":\"high\"}",
          "rationale": "The agent response provides a reality check on the infeasibility of curing cancer tomorrow and outlines a 6-month plan focusing on data sources (e.g., TCGA, CPTAC) and experiments, but it does not evaluate feasibility across skills (e.g., required ML expertise) or compute (e.g., hardware needs for multimodal models or WSI processing), as required by the rubric.",
          "confidence": "high",
          "score": 0.0
        }
      ]
    },
    "evidence_integrity": {
      "score": 1.0,
      "details": {
        "validity": 1.0,
        "rag_fidelity": 2.0
      }
    }
  },
  "judge_models": [
    "openrouter:google/gemini-2.5-flash-lite",
    "openrouter:deepseek/deepseek-v3.2-exp",
    "openrouter:x-ai/grok-4-fast"
  ],
  "output_label": "stage_c_mentor_metrics_oct21",
  "metrics_version": 2,
  "metrics_config_digest": "02ce838023f18d5d55c763e958282c8b763170b4fd1eac60c7b7445ce4e48453",
  "judge_prompt_digest": "45b272cee244d8cdeb02c717f98a4081be50d9cd712b6616c7240ae927ec513d",
  "citation_domains_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367",
  "metric_prompt_digests": {
    "rag_fidelity": "660c53926744ab90570c53c1f01f95a01418055d91d2d572548404a03d341213",
    "citation_relevance": "98e8253bb21908885984e8b0e785770109f8ba9d552643caf8ba1e3374ad890a",
    "source_fit": "52b3a41c4befe563c4dad55f6bd214485f3cc0131b5cf012675c50494bf7dcfc",
    "citation_quality": "5259dca527f992d0505c3ee9b5c3462b2a12897e148dbccd09312c272e4bf63d",
    "question_quality": "21ac2c52f156b8e695896d2ed07a15dd63eb2467ad3bb5f57c1e0dae7b99d80a",
    "actionability": "5d9aca0197762fc715b04d74d93cdc2b1e856fc08c308d2dcf7c28ab5a23f25e",
    "persona_compliance": "c27b9859c4cc18a4f43399259b5ffdb58e8c26904250229e6f92898eaf88ab18",
    "stage_awareness": "5b1b7f17ec0646db3d593e6dd649d1071bd6192f0ce5f23634ba8c3d467eef81",
    "tone_constructive": "e838330719f56aee975d84dc2fed7aeb1ed12fbe6af2763f3a1f52c76bf6f246",
    "expectation_management": "537d0916b79eefb7a55b23ef48d10cc981035067109054d7e29e04fe4e91470f",
    "plan_completeness": "f7d0e4d18670ffd18d4fb2b6c2b1f1db75a52b6f49956113b079dd6ff44e315f",
    "risk_mitigation": "0d372e749228777994b8302c4f4da77820fd56fa3bb11982a274fa3a3ec9f5a8",
    "feasibility_analysis": "1641c449a082419af5efdc972d708b763f96f0567dc9144a7ae89365076782b4"
  },
  "model_params": null,
  "model_spec": {
    "provider": null,
    "model": null,
    "system_id": "mentor_manual",
    "system_alias": null
  },
  "expected_checks": [
    "tool_routing",
    "rag_fidelity",
    "fallback_robustness",
    "citation_presence",
    "citation_validity",
    "citation_relevance",
    "source_fit",
    "citation_quality",
    "question_quality",
    "asks_questions",
    "actionability",
    "persona_compliance",
    "stage_awareness",
    "tone_constructive",
    "expectation_management",
    "plan_completeness",
    "risk_mitigation",
    "feasibility_analysis"
  ],
  "judge_parameters": [
    {
      "spec": "openrouter:google/gemini-2.5-flash-lite",
      "temperature": 0.0,
      "max_tokens": 1024
    },
    {
      "spec": "openrouter:deepseek/deepseek-v3.2-exp",
      "temperature": 0.0,
      "max_tokens": 1024
    },
    {
      "spec": "openrouter:x-ai/grok-4-fast",
      "temperature": 0.0,
      "max_tokens": 1024
    }
  ]
}